XBiotech/$XBIT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About XBiotech
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
Ticker
$XBIT
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
90
ISIN
CA98400H1029
Website
XBiotech Metrics
BasicAdvanced
$87M
-
-$1.29
0.97
-
Price and volume
Market cap
$87M
Beta
0.97
52-week high
$9.05
52-week low
$2.65
Average daily volume
57K
Financial strength
Current ratio
29.147
Quick ratio
28.934
Interest coverage (TTM)
-64.99%
Management effectiveness
Return on assets (TTM)
-13.78%
Return on equity (TTM)
-20.53%
Valuation
Price to book
0.5
Price to tangible book (TTM)
0.5
Price to free cash flow (TTM)
-2.765
Growth
Earnings per share change (TTM)
27.66%
3-year earnings per share growth (CAGR)
24.61%
XBiotech Financial Performance
Revenues and expenses
XBiotech Earnings Performance
Company profitability
XBiotech News
AllArticlesVideos
An Investigation Has Been Launched Into XBiotech Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
Accesswire·3 months ago
The Schall Law Firm Invites Shareholders With Losses In XBiotech Inc. To Join A Securities Fraud Investigation
Accesswire·3 months ago
The Schall Law Firm Invites Shareholders With Losses In XBiotech Inc. To Join A Securities Fraud Investigation
Accesswire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for XBiotech stock?
XBiotech (XBIT) has a market cap of $87M as of May 22, 2025.
What is the P/E ratio for XBiotech stock?
The price to earnings (P/E) ratio for XBiotech (XBIT) stock is 0 as of May 22, 2025.
Does XBiotech stock pay dividends?
No, XBiotech (XBIT) stock does not pay dividends to its shareholders as of May 22, 2025.
When is the next XBiotech dividend payment date?
XBiotech (XBIT) stock does not pay dividends to its shareholders.
What is the beta indicator for XBiotech?
XBiotech (XBIT) has a beta rating of 0.97. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.